KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Johnson & Johnson (JNJ) Payables (2016 - 2025)

Johnson & Johnson's Payables history spans 17 years, with the latest figure at $20.5 billion for Q4 2025.

  • For Q4 2025, Payables rose 25.73% year-over-year to $20.5 billion; the TTM value through Dec 2025 reached $20.5 billion, up 25.73%, while the annual FY2025 figure was $20.5 billion, 25.73% up from the prior year.
  • Payables for Q4 2025 was $20.5 billion at Johnson & Johnson, up from $16.0 billion in the prior quarter.
  • Across five years, Payables topped out at $27.9 billion in Q2 2023 and bottomed at $11.9 billion in Q2 2021.
  • The 5-year median for Payables is $14.8 billion (2022), against an average of $16.7 billion.
  • The largest YoY upside for Payables was 104.97% in 2023 against a maximum downside of 42.23% in 2023.
  • A 5-year view of Payables shows it stood at $12.8 billion in 2021, then rose by 14.25% to $14.6 billion in 2022, then decreased by 10.25% to $13.1 billion in 2023, then increased by 24.54% to $16.3 billion in 2024, then rose by 25.73% to $20.5 billion in 2025.
  • Per Business Quant, the three most recent readings for JNJ's Payables are $20.5 billion (Q4 2025), $16.0 billion (Q3 2025), and $21.0 billion (Q2 2025).